相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells
Usama Sharif Ahmad et al.
MOLECULAR ONCOLOGY (2022)
Pulmonary Alveolar Proteinosis and Multiple Infectious Diseases in a Child with Autosomal Recessive Complete IRF8 Deficiency
Jeremie Rosain et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2022)
Trimetazidine alleviates hypoxia/reoxygenation-induced apoptosis in neonatal mice cardiomyocytes via up-regulating HMGB1 expression to promote autophagy
Shiwen Lu et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2021)
Multidrug efflux transporter ABCG2: expression and regulation
Samiksha Kukal et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration
Joana Goncalves et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2
Sean A. Murphy et al.
NATURE COMMUNICATIONS (2021)
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance
Zhuo-Xun Wu et al.
CANCERS (2020)
Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
Chitra Rawat et al.
SCIENTIFIC REPORTS (2020)
PPARα activation directly upregulates thrombomodulin in the diabetic retina
Akira Shiono et al.
SCIENTIFIC REPORTS (2020)
PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
Wei Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy
Juan Chen et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling
Dahea You et al.
MOLECULAR NEUROBIOLOGY (2019)
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
Kevin Leandro et al.
PHARMACOLOGICAL RESEARCH (2019)
Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
Shansen Xu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Effects of carbamazepine on the P-gp and CYP3A expression correlated with PXR or NF-κB activity in the bEnd.3 cells
Xian-jin Ke et al.
NEUROSCIENCE LETTERS (2019)
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Sangita Sridharan et al.
FRONTIERS IN ONCOLOGY (2019)
Revisiting clinical practice in therapeutic drug monitoring of first-generation antiepileptic drugs
Shery Jacob et al.
DRUGS & THERAPY PERSPECTIVES (2019)
Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway
J. Xue et al.
ONCOGENE (2018)
Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor α Activation
Le Wang et al.
MOLECULAR PHARMACOLOGY (2018)
Clinical predictors of treatment outcome in North Indian patients on antiepileptic drug therapy: A prospective observational study
Chitra Rawat et al.
NEUROLOGY INDIA (2018)
PPAR-, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression
Vijay R. More et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies
Joanna Gesche et al.
EPILEPSIA (2017)
In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
Gurpreet Kaur Grewal et al.
MOLECULES (2017)
Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy
Aparna Banerjee Dixit et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Development and Function of the Blood-Brain Barrier in the Context of Metabolic Control
Roberta Haddad-Tovolli et al.
FRONTIERS IN NEUROSCIENCE (2017)
In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells
Robim M. Rodrigues et al.
ARCHIVES OF TOXICOLOGY (2016)
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Hans C. Helms et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Hydrogen Sulfide Up-Regulates the Expression of ATP-Binding Cassette Transporter A1 via Promoting Nuclear Translocation of PPARα
Dong Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The impact of PPARα activation on whole genome gene expression in human precision cut liver slices
Aafke W. F. Janssen et al.
BMC GENOMICS (2015)
Antiepileptic drugs alter the expression of placental carriers: An invitro study in a human placental cell line
Miriam Rubinchik-Stern et al.
EPILEPSIA (2015)
In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier
Md. Tozammel Hoque et al.
JOURNAL OF NEUROCHEMISTRY (2015)
The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)
Kerstin Roemermann et al.
NEUROPHARMACOLOGY (2015)
Marked Differences in the Effect of Antiepileptic and Cytostatic Drugs on the Functionality of P-Glycoprotein in Human and Rat Brain Capillary Endothelial Cell Lines
Dana Alms et al.
PHARMACEUTICAL RESEARCH (2014)
Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models
Haruka Nakanishi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells
Denis A. Mogilenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid
Lobna M. Eldasher et al.
TOXICOLOGY (2013)
The hCMEC/D3 cell line as a model of the human blood brain barrier
Babette Weksler et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
Yakun Chen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Regulation of Breast Cancer Resistant Protein by Peroxisome Proliferator-Activated Receptor α in Human Brain Microvessel Endothelial Cells
Md. Tozammel Hoque et al.
MOLECULAR PHARMACOLOGY (2012)
Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected
Wolfgang Loescher et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Xenobiotic Metabolism, Disposition, and Regulation by Receptors: From Biochemical Phenomenon to Predictors of Major Toxicities
Curtis J. Omiecinski et al.
TOXICOLOGICAL SCIENCES (2011)
A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy
Won-Joo Kim et al.
PHARMACOGENETICS AND GENOMICS (2010)
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Maryam Rakhshandehroo et al.
PPAR RESEARCH (2010)
Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs
Laura Lombardo et al.
CURRENT NEUROVASCULAR RESEARCH (2008)
Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus
Jens P. Bankstahl et al.
EPILEPSY RESEARCH (2008)
Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain
Tao Wen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro
Hui-wen Yang et al.
NEUROSCIENCE LETTERS (2008)
PPARα agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine
Toshitake Hirai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats
E. A. van Vliet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor α
JS Moffit et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Lack of interactions between breast cancer resistance protein (BCRP/ABCG2) and selected antiepileptic agents
L Cerveny et al.
EPILEPSIA (2006)
Statistical analysis of real-time PCR data
JS Yuan et al.
BMC BIOINFORMATICS (2006)
New proteins configure a brain drug resistance map in tuberous sclerosis
AJ Lazarowski et al.
PEDIATRIC NEUROLOGY (2006)
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
S Remy et al.
BRAIN (2006)
Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats
EA van Vliet et al.
EPILEPSIA (2005)
Multidrug resistance in epilepsy:: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures
HA Volk et al.
BRAIN (2005)
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain
E Aronica et al.
EPILEPSIA (2005)
Potential role of drug transporters in the pathogenesis of medically intractable epilepsy
P Kwan et al.
EPILEPSIA (2005)
Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s)
S Hori et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Role of multidrug transporters in pharmacoresistance to antiepileptic drugs
W Löscher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The peroxisome proliferator-activated receptor α-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain
TE Cullingford et al.
NEUROPHARMACOLOGY (2002)
Pharmacological and therapeutic properties of valproate - A summary after 35 years of clinical experience
E Perucca
CNS DRUGS (2002)
Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
SM Dombrowski et al.
EPILEPSIA (2001)
Peroxisome proliferator-activated receptor δ is a specific sensor for teratogenic valproic acid derivatives
A Lampen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α -: PPARα fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression
JW Lawrence et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells
K Terashi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
